Detalles de la búsqueda
1.
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma.
Haematologica
; 106(9): 2405-2416, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32817282
2.
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Hematol Oncol
; 38(4): 501-508, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32602970
3.
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Haematologica
; 104(11): 2241-2248, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31666344
4.
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.
Biol Blood Marrow Transplant
; 20(4): 501-6, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24374214
5.
Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy.
Future Oncol
; 10(16): 2569-78, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947121
6.
Persistent CD30 expression by embryonal carcinoma in the treatment time course: prognostic significance of a worthwhile target for personalized treatment.
J Urol
; 190(5): 1919-24, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23624209
7.
The lymphocyte to monocyte ratio improves the IPI-risk definition of diffuse large B-cell lymphoma when rituximab is added to chemotherapy.
Am J Hematol
; 88(12): 1062-7, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23940056
8.
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
Br J Haematol
; 152(5): 551-60, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21166786
9.
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11).
Ann Hematol
; 90(4): 401-8, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20872000
10.
Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody.
Cells
; 9(10)2020 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023194
11.
A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy.
Front Immunol
; 10: 2514, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708930
12.
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells.
MAbs
; 10(7): 1084-1097, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29993310
13.
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
J Clin Oncol
; 36(5): 454-462, 2018 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360414
14.
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.
Cancer Biother Radiopharm
; 22(1): 113-20, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17627419
15.
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Haematologica
; 91(2): 255-7, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16461314
16.
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
Haematologica
; 91(12): 1635-43, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17145600
17.
TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site.
Clin Cancer Res
; 22(14): 3499-512, 2016 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26944067
18.
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.
J Clin Oncol
; 34(33): 4015-4022, 2016 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28199143
19.
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
Curr Gene Ther
; 5(5): 511-21, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16250891
Resultados
1 -
19
de 19
1
Próxima >
>>